Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:e7
Published online before print January 14, 2008, doi: 10.1161/HYPERTENSIONAHA.107.108373
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/e7    most recent
HYPERTENSIONAHA.107.108373v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calhoun, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Calhoun, D. A.
Related Collections
Right arrow Clinical Studies

(Hypertension. 2008;51:e7.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Response to About an Epidemic of Primary Aldosteronism

David A. Calhoun

Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama

I appreciate Plouin’s1 thoughtful comments. In discussing idiopathic hyperaldosteronism, I was referring back to Padfield’s work2 indicating that the underlying pathophysiologies of idiopathic versus primary aldosteronism secondary to an aldosterone-producing adenoma are different, with the former seeming to manifest a heightened response to angiotensin II and the latter a blunted response. This is not to suggest that idiopathic hyperaldosteronism is distinct from primary aldosteronism, as I agree that it is a subtype of the disorder.

I further agree with Plouin1 that suppression testing cannot distinguish between the 2 subtypes of primary aldosteronism. As discussed in my review, lateralization of aldosterone secretion by adrenal vein sampling is required to confirm a probable aldosterone-producing adenoma and a likely favorable response to surgery.


*    Acknowledgments
 
Disclosures

None.


*    References
up arrowTop
*References
 
1. Plouin PF. About an epidemic of primary aldosteronism. Hypertension. 2008: 51: e6.[Free Full Text]

2. Padfield PL. Primary aldosteronism, a common entity? The myth persists. J Human Hypertens. 2002; 16: 159–162.[CrossRef][Medline] [Order article via Infotrieve]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/e7    most recent
HYPERTENSIONAHA.107.108373v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calhoun, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Calhoun, D. A.
Related Collections
Right arrow Clinical Studies